Status:
COMPLETED
The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy
Lead Sponsor:
Fudan University
Conditions:
Information Support
Eligibility:
MALE
Up to 80 years
Phase:
NA
Brief Summary
The incidence rate of prostate cancer has been increasing rapidly in China in recent years. However, a large number of studies have shown that, patients with prostate cancer during hormonal therapy ge...
Detailed Description
The incidence rate of prostate cancer has been increasing rapidly in China in recent years. It has gradually become one of the most common malignant tumors of the urinary system in men. However, a lar...
Eligibility Criteria
Inclusion
- Patients were diagnosed as prostate cancer by biopsy or operation; At the initial stage of hormonal therapy for prostate cancer (0-3 months); The time of hormonal therapy was expected more than 6 months; Master basic operation skills of the app "wechat", or can simply use it after learning; Primary school education or above; Age \< 80; Have a clear sense of reading, understanding and communication skills; Willing to participate in this study and sign informed consent.
Exclusion
- Have received castration operation; Combined with other tumors; Combined with other serious endocrine diseases; Serious diseases in heart, brain, lung or other important organs.
Key Trial Info
Start Date :
November 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04340713
Start Date
November 22 2018
End Date
February 29 2020
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rui Yang
Shanghai, China